<List><item><source>MED</source><extId>26229484</extId><pmcid>PMC4514349</pmcid><annotations><annotation><prefix>eligible for intensive chemotherapy (</prefix><exact>NCT00091234</exact><postfix>). </postfix><tags><tag><name>NCT00091234</name><uri>http://identifiers.org/clinicaltrials/NCT00091234</uri></tag></tags><id>http://europepmc.org/articles/PMC4514349#europepmc-b62d386f4225030cb61fb643abfb9c3a</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix> patients (POLO-AML-2, </prefix><exact>NCT01721876</exact><postfix>) was initiated. </postfix><tags><tag><name>NCT01721876</name><uri>http://identifiers.org/clinicaltrials/NCT01721876</uri></tag></tags><id>http://europepmc.org/articles/PMC4514349#europepmc-519b1db081360209b6390cc3f541580e</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation></annotations></item></List>